Rockefeller Capital Management
DARE icon

Rockefeller Capital Management’s Dare Bioscience DARE Stock Holding History

Rockefeller Capital Management’s Portfolio DARE Stock Details DARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-17
Closed – – 3806
2021
Q3 		$0 Hold
17
– – ﹤0.01% 3714
2021
Q2 		$0 Hold
17
– – ﹤0.01% 3464
2021
Q1 		$0 Buy
+17
New +$415 ﹤0.01% 3269

Other funds holding DARE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
FFS
Founders Financial Securities Towson, Maryland $1.77B AUM 17.63% 1-Year Est. Return

Rockefeller Capital Management's DARE Position: Q4 2021 in Review

Rockefeller Capital Management sold out of Dare Bioscience (DARE) in Q4 2021, closing a stake of 17 shares.

Rockefeller Capital Management first reported a position in DARE in Q1 2021 and held it in 3 quarters. The position peaked at $0 in Q3 2021. 38 funds tracked by Wall St. Rank hold DARE as of Q4 2021.

  • Rockefeller Capital Management reported no remaining Dare Bioscience position as of Q4 2021 after selling out during the quarter.
  • Rockefeller Capital Management sold 17 Dare Bioscience shares in Q4 2021.
  • Rockefeller Capital Management first reported a position in Dare Bioscience in Q1 2021 and held it in 3 quarters.
  • Rockefeller Capital Management's Dare Bioscience position peaked at $0 in Q3 2021.
  • 38 funds tracked by Wall St. Rank held Dare Bioscience as of Q4 2021.

Based on Rockefeller Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.